Jeff Berkowitz

Jeff Berkowitz is a Senior Adviser to the global Healthcare team at Permira, a global private equity firm.1 He brings over 30 years of experience in the global healthcare industry to this role.23

Professional Background

Jeff Berkowitz is currently the Chief Executive Officer of Real Endpoints, a company that provides insights and tools to strengthen access to pharmaceutical innovations.3 He has an extensive career in the healthcare industry, having held several leadership positions:

• Executive roles at UnitedHealth Group/Optum, where he led Optum's international division as CEO13
• Member of the Executive Committee at Walgreens Boots Alliance, serving as President of Pharma and Global Market Access13
• Senior leadership roles at Merck & Co.3

Board Positions

Berkowitz serves on multiple boards, including:

• Board of Directors for Lundbeck A/S, Uniphar, Zealand Pharma, and Click Therapeutics13
• Chairman of PharmaTwoB13

Education and Early Career

An attorney by training, Berkowitz began his career with the global law firm Proskauer, LLP.13 He received his undergraduate degree from Union College (New York) and his graduate degree from Brooklyn Law School.4

Role at Permira

As a Senior Adviser at Permira, Berkowitz works with teams across the globe, leveraging his industry knowledge, global network, and sector expertise to support the firm's investment activities and portfolio value creation.1 His appointment to this role was announced on November 7, 2023.15